These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 5514620)

  • 1. 3-N,N-bis(2-chloroethylamino)p-toluic acid, a new cytostatic drug active in cancer.
    Dobre V; Maltezeanu G
    Cancer Chemother Rep; 1970 Oct; 54(5):319-23. PubMed ID: 5514620
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential anticancer agents. V. New aromatic nitrogen mustards related to 3-[N,N-bis(2-chloroethyl)amino]-4-methylbenzoic acid.
    Cambanis A; Dobre V; Niculescu-Duvăz I
    J Med Chem; 1969 Jan; 12(1):161-4. PubMed ID: 5763014
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential antitumor agents: steroidal amidoesters with an alkylating moiety.
    Papageorgiou A; Boutis L; Nicolaropoulos S; Catsoulacos P
    Oncology; 1987; 44(2):128-32. PubMed ID: 3574853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The significance of connective tissue stimulation in antitumor chemotherapy].
    Diadosha GF; Bulkina ZP; Kononenko LI
    Vopr Onkol; 1968; 14(9):70-3. PubMed ID: 4971964
    [No Abstract]   [Full Text] [Related]  

  • 5. [The mechanism of tumor drug resistance].
    Kulik GI
    Vopr Onkol; 1969; 15(11):60-4. PubMed ID: 5368841
    [No Abstract]   [Full Text] [Related]  

  • 6. The need for additional alkylating agents.
    Connors TA
    Cancer Res; 1969 Dec; 29(12):2433-7. PubMed ID: 5369691
    [No Abstract]   [Full Text] [Related]  

  • 7. Synergistic effects of bis(3-methylsulfonyloxypropyl)-amine toluenesulfonate (864-T) with 6-mercaptopurine and other antitumor agents.
    Imamura H; Ikegami K; Okumoto T
    Gan; 1973 Oct; 64(5):427-31. PubMed ID: 4358730
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental study of the antitumor activity and toxicity of the preparation, Peptichemio].
    Balitskiĭ KP; Veksler IG; Tsapenko VF
    Vopr Onkol; 1979; 25(7):105. PubMed ID: 483671
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative antitumor effects of peptichemio and other alkylating agents.
    Schmid FA; Banks SE; Stock CC
    Cancer Treat Rep; 1977; 61(3):473-5. PubMed ID: 872145
    [No Abstract]   [Full Text] [Related]  

  • 10. A mouse ependymoblastoma as an experimental model for screening potential antineoplastic drugs.
    Geran RI; Congleton GF; Dudeck LE; Abbott BJ; Gargus JL
    Cancer Chemother Rep 2; 1974 Dec; 4(4):53-87. PubMed ID: 4447935
    [No Abstract]   [Full Text] [Related]  

  • 11. Carcinogenicity of alkylating cytostatic drugs in animals.
    Berger MR
    IARC Sci Publ; 1986; (78):161-76. PubMed ID: 3583389
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cytostatic effect of 1-methyl-2-(p-(bis-(beta-chlorethyl)-amino)-phenyliminomethyl)-quinolinium chloride (IMET 3106) on the growth of transplantable neoplasms].
    Jungstand W; Gutsche W; Wohlrabe K
    Arch Geschwulstforsch; 1972; 40(1):35-9. PubMed ID: 4510766
    [No Abstract]   [Full Text] [Related]  

  • 13. A mitomycin C-resistant Jensen rat sarcoma: chemotherapy studies.
    Sugiura K; Merker PC
    Cancer Res; 1963 Sep; 23(8 Pt 2):1475-82. PubMed ID: 5878213
    [No Abstract]   [Full Text] [Related]  

  • 14. A study of chromosomal behaviour in primary tumour cells and lymphatic metastases under the action of the cytostatic IOB 82.
    Andreescu M; Dobre V; Maltezeanu G; Mateescu C
    Neoplasma; 1970; 17(5):475-83. PubMed ID: 5486298
    [No Abstract]   [Full Text] [Related]  

  • 15. [Correlations between the chemical structure of Mannich bases with and without nitrogen mustard groups and their cytostatic effect on Ehrlich ascites carcinoma in albino mice].
    Werner W; Jungstand W; Gutsche W
    Arzneimittelforschung; 1970 Feb; 20(2):246-9. PubMed ID: 5467470
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of serotonin on the antineoplastic activity and toxicity of sarcolysin and dopan].
    Mal'tseva LF
    Farmakol Toksikol; 1966; 29(6):698-701. PubMed ID: 6000367
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination chemotherapy in isolation perfusion: use of mitotic inhibitors in pretreatment of V x 2 carcinoma undergoing isolation perfusion with alkylating agents.
    Mashima Y; Nagatsu M; Lambert A
    Cancer Chemother Rep; 1972 Apr; 56(2):175-81. PubMed ID: 5043225
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU.
    Young RC; DeVita VT; Serpick AA; Canellos GP
    N Engl J Med; 1971 Aug; 285(9):475-9. PubMed ID: 5558887
    [No Abstract]   [Full Text] [Related]  

  • 19. [Aromatic N-mustard compounds. 1. Derivatives of 3-N, N-bis-(2-chlorethyl)amino-4-methylbenzoid acid].
    Cambanis A; Gericke D
    Arzneimittelforschung; 1975 Jan; 25(1):1-9. PubMed ID: 1173761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antineoplastic activity of new preparations from the chlorethylamine group not affecting hemopoiesis].
    Vasil'eva LS; D'iachkovskaia RF; Shuppe NG; Parkhomenko II; Surkova NI
    Izv Akad Nauk SSSR Biol; 1970; 3():459-63. PubMed ID: 5491977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.